Administration of recombinant murine TNF-α to mice with chronic schistosomal infection has increased the size of liver granulomas, and injections of polyclonal anti-TNF-α into acutely infected mice have suppressed the size of developing granulomas [23]. Here, TNF is linked to digestive system neoplasm.